MRI of the spinal cord may be an effective way to inform early treatment of spinal muscular atrophy (SMA) and monitor the disease, according to a case report published in the January-February issue of Clinical Imaging.

Quantib, a medical technology company based out of Rotterdam, the Netherlands, has received FDA clearance for its Quantib Neurodegenerative (ND) solution.

Overall cancer deaths in the United States have steadily declined by 27 percent over the past quarter century, according to a new review from the American Cancer Society (ACS).

Queen Elizabeth II Health Sciences Centre in Halifax, Nova Scotia, Canada, is soon to be home to the first MRI scanner in an emergency department in the entire province.

The findings suggest the evaluation of molecular biomarkers for Alzheimer’s disease should be adjusted for race, as African American patients were found to have lower levels of tau—a key biomarker used to identify the disease, according to research published online Jan. 7 in JAMA Neurology.

An AI-driven approach for detecting an early sign of diabetic retinopathy achieved an accuracy rate of more than 98 percent, according to a study published in Computers in Biology and Medicine. The results could mean a quicker and cheaper solution for diagnosing the disease earlier and possibly prevent loss of eyesight.

A team of Dutch researchers has developed a real-time hybrid fluoroscopic and nuclear imaging detector that may aid interventional radiology (IR) procedures such as radioembolization, according to authors of a Jan. 8 study published in Radiology.

Healthcare providers should consider treating men and women with glioblastoma (GBM) in different ways, according to a study published in Science Translational Medicine.